NordiQC

Home ■ Participation ■ Assessments ■ Epitopes ■ Protocols ■ Techniques ■ Links

Previous protocols

Recommended protocols from NordiQC assessment schemes

Among protocols shown to give optimal staining results, one or more are selected to cover a spectrum of laboratories, antibodies and techniques.

Previously recommended protocols are listed here.

The latest recommended protocols for each antibody/clone/epitope are in Current protocols.

mAb = monoclonal antibody, pAb = polyclonal antibody

Epitope	Antibody	Protocols from previous runs
A B C D E F G H M K P S T V
AMACR	mAb 13H4	Sønderborg, DK (Run 16) ■ Umeå, SE (Run 16)
	pAb ab12498	St.-Petersburg, RU (Run 16)
	pAb CP200C	Rovaniemi, FI (Run 16)
ASMA	mAb 1A4	Malmö, SE (Run 10) ■ Sønderborg, DK (Run 10) ■ Täby, SE (Run 10)
Bcl-2	mAb 124	Aalborg, DK (Run 3) ■ Tampere, FI (Run 3)
bcl-6	mAb PG-B6p	Aalborg, DK (Run 4)
Calretinin (CR)	mAb 5A5	Hillerød, DK (Run 17) ■ Hillerød, DK (Run 19) ■ Ålesund, N (Run 6)
	mAb DAK-Calret 1	Molde, NO (Run 19) ■ Næstved, DK (Run 17) ■ Saskatoon, CA (Run 17) ■ Skive, DK (Run 6)
	pAb 18-0211	Trondheim, NO (Run 17) ■ Wien, AT (Run 19)
	pAb 7699/4	Odense, DK (Run 19)
CD3	mAb F7.2.38	Skien, NO (Run 14)
	mAb PS1	Castelfranco Veneto, IT (Run 14) ■ Guangzhou, CHN (Run 14) ■ Rad.hosp. Oslo, NO (Run 5)
	mAb SP7	Ålesund, NO (Run 14)
	pAb A0452	Holbæk/Slagelse, DK (Run 14) ■ Lindköping, SE (Run 5)
	pAb RB-360-A	Rovaniemi, FI (Run 14)
CD5	mAb 4C7	Aalborg,DK (Run 3) ■ Aliso Viejo, USA (Run 17) ■ Glostrup, DK (Run 8) ■ Lahti, FI (Run 17) ■ Oslo, NO (Run 3) ■ Skien, NO (Run 8)
	mAb CD5/54/F6	Hjørring/Brønderslev, DK (Run 8)
	rmAb SP19	Anonymous (Run 17) ■ Rotterdam, NL (Run 17)
CD10	mAb 56C6	Hillerød, DK (Run 6) ■ Karlstad, SE (Run 6)
CD15	mAb C3D-1	Glostrup, DK (Run 10) ■ Oslo, NO (Run 3) ■ Rijeka, HR (Run 22) ■ Örebro, SE (Run 14)
	mAb Carb-3	Gentofte, DK (Run 22)
	mAb MMA	Aalborg, DK (Run 3) ■ Firenze, IT (Run 22) ■ Karlstad, SE (Run 10) ■ Tampere, FI (Run 14) ■ Treviglio, IT (Run 14) ■ Vienna, AT (Run 22)
	mAb Tu9	Anonymous (Run 10)
CD20	mAb L26	Helsingborg, SE (Run 6) ■ Skive, DK (Run 6)
CD23	mAb 1B12	Esbjerg, DK (Run 9) ■ Odense, DK (Run 9) ■ Randers, DK (Run 19) ■ Roskilde, DK (Run 19) ■ Skien, NO (Run 9) ■ Uppsala, SE (Run 19)
	mAb MHM6	Stavanger, NO (Run 9)
	rmAb SP23	Trondheim, NO (Run 19)
CD30	mAb Ber-H2	Borås, SE (Run 11) ■ Firenze, IT (Run 11) ■ Jönköping, SE (Run 11) ■ Odense, DK (Run 11) ■ Trondheim, NO (Run 11)
CD31	mAb JC/70A	Odense, DK (Run 11) ■ Skien, NO (Run 11) ■ Sundsvall, SE (Run 11) ■ Århus, DK (Run 11)
CD34	mAb QBEnd 10	Aalborg, DK (Run 1)
CD68	mAb KP1	Oslo, NO (Run 11) ■ Växjö, SE (Run 11)
CD68	mAb PG-M1	Helsingborg, SE (Run 11) ■ Stockholm, SE (Run 11)
CD79a	mAb JCB117	Carolinska Sgh, Stockholm, SE (Run 6) ■ Vejle, DK (Run 6)
CD117	pAb A4502	Aalborg, DK (Run 4) ■ Bergen, NO (Run 14) ■ Lindköping, SE (Run 7) ■ Næstved, DK (Run 21) ■ Rotterdam, NL (Run 21) ■ Sundsval, SE (Run 21) ■ Trondheim, NO (Run 4) ■ Trondheim, NO (Run 7) ■ Vejle, DK (Run 7) ■ Vestfold, NO (Run 7) ■ Vilnius, LT (Run 21) ■ Århus, DK (Run 14)
Chromogranin	mAb LK2H10	Aalborg, DK (Run 13) ■ Firenze, IT (Run 18) ■ Lund, SE (Run 2) ■ Uppsala, SE (Run 9) ■ Uppsala, SE (Run 18)
	mAb LK2H10+PHE5	Jyväskylä, FI (Run 9) ■ Jyväskylä, FI (Run 13) ■ Jyväskylä, FI (Run 18)
	pAb A0430	Danderyd Stockholm; SE (Run 13) ■ Helsingborg, SE (Run 18) ■ Helsingki, FI (Run 9) ■ Reykjavik, IS (Run 18) ■ RH. København, DK (Run 2) ■ Vejle, DK (Run 9)
Cyclin D1	mAb P2D11F11	Næstved, DK (Run 9) ■ Seinäjoki, FI (Run 9) ■ Uppsala, SE (Run 9)
	mAb SP4	Drammen, NO (Run 17) ■ Trollhättan, SE (Run 17) ■ Ålesund, NO (Run 9)
	pAb CP236	Skive, DK (Run 17)
Cytokeratin, high molecular weight	mAb 34BE12	Malmö, SE (Run 16) ■ Skien, NO (Run 16) ■ Triviglio, IT (Run 16)
	mAb D5/16 B4	Odense, DK (Run 16)
	mAb XM26	Karlstad, SE (Run 16)
Cytokeratin, low molecular weight	mAb 5D3	Jönköping, SE (Run 9) ■ Rotterdam, NL (Run 20)
	mAb C-51	Aalborg, DK (Run 2) ■ Hjørring, DK (Run 20) ■ Tampere, FI (Run 9) ■ Tampere, FI (Run 16)
	mAb CAM 5.2	Edmonton, CA (Run 20) ■ Lindköping, SE (Run 9) ■ Oslo, NO (Run 2)
	mAb DC10	Eindhoven, NL (Run 16) ■ Esbjerg, DK (Run 16) ■ Reykjavik, IS (Run 20) ■ Roskilde, DK (Run 9) ■ Treviglio, IT (Run 20)
Cytokeratin 7	mAb K72	Anonymous (Run 8)
	mAb K72.7	Jyväskylä, FI (Run 8)
	mAb OV/TL 12/30	Borås, SE (Run 8) ■ Oslo, NO (Run 8)
Cytokeratin 20	mAb Ks 20.8	Molde, NO (Run 8) ■ Seinäjoki, FI (Run 8) ■ Växjö, SE (Run 8)
Cytokeratin, pan-	mAb AE1/AE3	Bodø, NO (Run 20) ■ Helsingborg, SE (Run 15) ■ Karlskrona, SE (Run 20) ■ Odense, DK (Run 8)
	mAb AE1/AE3+5D3	Esbjerg, DK (Run 20) ■ RH. København, DK (Run 8) ■ RH, København, DK (Run 15)
	mAb Ab-2	Rovaniemi, FI (Run 15)
	mAb KL1	Bispebjerg, København, DK (Run 20) ■ Esbjerg, DK (Run 15) ■ Skive, DK (Run 8)
	mAb MNF116	Bergen, NO (Run 15) ■ Trollhättan, SE (Run 20)
	mAb Pan CK, Ab2	Ålesund, NO (Run 20)
Desmin	mAb D33	Lund, SE (Run 5)
Desmin	mAb DE-R-11	Odense, DK (Run 5)
Epithelial antigen (Ep-CAM)	mAb Ber-EP4	Bispebjerg Hosp., Kbh., DK (Run 6) ■ Bodø, NO (Run 17) ■ Lund, SE (Run 17) ■ RH, Kbh., DK (Run 6)
	mAb MOC-31	Odense, DK (Run 17)

Estrogen receptor	mAb 1D5	Bispebjerg Hosp., Kbh., DK (Run 13) ■ Esbjerg, DK (Run 10) ■ Halmstad, SE (Run B1) ■ Halmstad, SE (Run B3) ■ Hjørring/Brønderslev, DK (Run 8) ■ Hjørring, DK (Run B5) ■ Trondheim, NO (Run 8)
	mAb1D5 and ER-2-123	Anonymous (Run B1) ■ Anonymous (Run B5)
	mAb 6F11	Gävle, SE (Run 10) ■ Helsinki, FI (Run B1) ■ Helsinki, FI (Run B5) ■ Irvine, USA (Run B1) ■ Jönköping, SE (Run 8) ■ Karlstad, SE (Run 8) ■ Odense, DK (Run 10) ■ Roskilde, DK (Run B3) ■ Roskilde, DK (Run B5) ■ Stavanger, NO (Run 13)
	rmAb SP1	Aalborg, DK (Run 10) ■ Kalmar, SE (Run B1) ■ Karolinska Stockholm, SE (Run 13) ■ Roermond, NL (Run B3) ■ Roermond, NL (Run B5) ■ Skien, NO (Run B3) ■ Vejle, DK (Run B5)
Glial fibrillary acidic protein	mAb 6F2	Karlstad, SE (Run 4)
Glial fibrillary acidic protein	pAb Z0334	Aalborg, DK (Run 4)
HER-2	mAb 4B5	Treviglio, IT (Run B2)
	mAb CB11	Turku, FI (pilot run) ■ Roskilde, DK (Run B6)
	rmAb SP3	Drammen, NO (Run B2) ■ Tilburg, NL (Run B4)
	pAb A0485	Dresden, DE (Run B4) ■ Genk, BE (Run B5) ■ Guangzhou, CHN (Run B2) ■ Luleå, SE (Run B3) ■ Stockholm, SE (pilot run) ■ Vienna, AT (Run B6)
	pAb 28-0004	Helsingborg, SE (pilot run)
	HercepTest	Aliso Viejo, USA (Run B5) ■ Antwerp, BE (Run B6) ■ Hjørring, DK (pilot run) ■ Vejle, DK (Run B2)
	Pathway^®	Castelfranco Veneto, IT (Run B5) ■ Frederiksstad, NO (pilot run) ■ Roermond, NL (Run B6)
IgK	pAb A0191	Odense, DK (Run 18) ■ Stavanger, NO (Run 15) ■ Seinäjoki, FI (Run 15) ■ Seinäjoki, FI (Run 18)
IgM	pAb A0425	Hvidovre, DK (Run 18) ■ Skövde, SE (Run 18)
Ki-67	mAb K2	's-Hertogenbosch, NL (Run 19)
	mAb MIB-1	Esbjerg, DK (Run 19) ■ Herlev, DK (Run 5) ■ Trondheim, NO (Run 5) ■ Trondheim, NO (Run 19) ■ Århus, DK (Run 19)
	mAb MM1	Kiev, UA (Run 19)
	rmAb 30-9	Tønsberg, NO (Run 19)
	rmAb SP6	Linz, AT (Run 19) ■ Ålesund, NO (Run 19)
MLA	mAb A103	Danderyd, Stockholm, SE (Run 20) ■ Dresden, DE (Run 20) ■ Jönköping, SE (Run 16) ■ Karlstad, SE (Run 7) ■ Norbyhagen, NO (Run 7) ■ Stavanger, NO (Run 16) ■ Wien, AT (Run 20)
	mAb A103+M2+7C10+M2-9E3	Helsinki, FI (Run 20)
	mAb M2-7C10+M2-9E3	Jyväskylä, FI (Run 7)
Mismatch repair proteins MSH2	mAb 25D12	Aalborg, DK (Run 13)
	mAb 27	Odense, DK (Run 13)
	mAb FE11	Ålesund, NO (Run 13)
MSA-HMB45	mAb HMB45	Jyväskylä, FI (Run 7) ■ Norbyhagen, NO (Run 7) ■ Sønderborg, DK (Run 7) ■ Västerås, SE (Run 7)
p53	mAb DO-7	Tampere, FI (Run 2)
Placental alkaline phosphatase	mAb NB10	Firenze, IT (Run 14)
Placental alkaline phosphatase	mAb PL8-F6	Sønderborg, DK (Run 14) ■ Uppsala, SE (Run 14)
Progesterone receptor	mAb 16	Karlstad, SE (Run 10) ■ Næstved, DK (Run B2) ■ Roskilde, DK (Run B4)
	mAb 1A6	Gävle, SE (Run10)
	mAb 1E2	Nieuwegein, NL (Run B2)
	mAb PgR 636	Danderyd, Stockholm, SE ■ (Run 10)Skien, NO (Run B2) ■ Wien, AT (Run B4)
	mAb PgR 1294	Aliso Viejo, USA (Run B2)
	mAb PR88	Skive, DK (Run 10)
	rmAb 1E2	Århus, DK (Run B4)
	rmAb SP2	Kalmar, SE (Run B2) ■ Wien, AT (Run B4)
S-100	pAb Z0311	Borås, SE (Run 7) ■ Hjørring/Brønderslev, DK (Run 7) ■ Odense, DK (Run 7)
SYP	mAb 27G12	Gävle, SE (Run 18) ■ Trollhättan, SE (Run 18)
	mAb Snp88	Gentofte, DK (Run 18) ■ Næstved, DK (Run 5) ■ Roskilde, DK (Run 18)
	mAb SP11	Eindhoven, NL (Run 18)
	pAb A0010	Herlev, DK (Run 5) ■ Ålesund, NO (Run 18)
	pAb RB-9044	Fujian, CHN (Run 18)
TTF-1	mAb 8G7G3/1	Herlev, DK (Run 9) ■ Jyväskylä, FI (Run 9)
TTF-1	mAb SPT24	Dramme, NO (Run 19) ■ Hjørring, DK (Run 9) ■ Linköping, SE (Run 19) ■ Luleå, SE (Run 9) ■ Roskilde, DK (Run 19) ■ Sarajevo, BA (Run 19) ■ Ålesund, NO (Run 19)

MV/SN/AS

Last update 06-07-2009